Filing Details
- Accession Number:
- 0000950170-25-052255
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-04-08 19:05:30
- Reporting Period:
- 2025-03-31
- Filing Date:
- 2025-04-08
- Accepted Time:
- 2025-04-08 19:05:30
- Original Submission Date:
- 2025-04-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1607678 | Viking Therapeutics Inc. | VKTX | Pharmaceutical Preparations (2834) | 461073877 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761366 | Kathryn Sarah Rouan | C/O Viking Therapeutics, Inc. 9920 Pacific Heights Blvd, Suite 350 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2025-03-31 | 1,240 | $24.15 | 1,240 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person's purchase of shares of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 1,240 shares, with the Reporting Person's sale of shares of the Issuer's common stock at a price of $80.89 per share on October 25, 2024. The Reporting Person has, on a voluntary basis, made arrangements with the Issuer to pay $70,316.25 to the Issuer, representing the full amount of the profit realized in connection with the short-swing transaction, less transactions costs.
Billionaire Hedge Funds
